VAXEQUITY
AstraZeneca invests in Imperial's self-amplifying RNA technology with eye on future drugsVaxEquity, a startup founded by Imperial vaccinologist Robin Shattock, could receive up to $195 million if certain milestones are met, in a...
- Load More